Vortex “As a clinician, I am excited about accessing the cancer biology of patient’s through CTCs. Vortex’s technology provides the best source of CTCs to aid in the diagnostic and treatment decisions we face every day.” – Dr. Jonathan Goldman, MD, Director of Clinical Trials in Thoracic Oncology, Associate Director of Drug Development at UCLA “Improving CTCs recovery along with high cellular purity while maintaining viability have tremendous value for translational research and clinical diagnostic applications. The VTX-1 holds the potential to revolutionize blood-based diagnostics.” - Pr. Massimo Cristofanilli, MD, FACP, Professor of Medicine, Associate Director of Translational Research and Precision Medicine, Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine Wanda J. Cribbs, Lead Gartner Analyst Population Health & Analytics says: "Wanda's recent HRS press release really stands out. Delivering those results and having a client publicly share credit with their vendor is rare and says a lot. We at Gartner will have our eyes on Wanda in 2018"

Disclaimer – Important

TERMS OF ACCESS

PLEASE READ CAREFULLY THE TERMS AND CONDITIONS SET OUT BELOW. IF YOU ACCESS THIS SECTION OF THE WEBSITE OR ANY OF THE INFORMATION IT CONTAINS, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET OUT BELOW. IF YOU DO NOT AGREE TO THE TERMS AND CONDITIONS, DO NOT ACCESS THIS SITE OR ANY OF ITS INFORMATION.

THESE MATERIALS ARE FOR INFORMATIONAL PURPOSES ONLY AND ARE NOT DIRECTED TO, NOR ARE THEY INTENDED FOR, ACCESS BY PERSONS LOCATED OR RESIDENT IN THE UNITED STATES, THE REPUBLIC OF IRELAND, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF, OR REQUIRE REGISTRATION THEREUNDER IN, SUCH JURISDICTION.

Please read this notice carefully – it applies to all persons who view this site. Please note that the disclaimer set out below may be altered or updated. You should read it in full each time you visit the site.

Visitors to this website are encouraged to seek individual advice from their personal, financial, legal, tax and other appropriate advisers before making any investment or financial decisions or purchasing any financial, securities or investment related service or product.

The release, publication or distribution of the documents or other information contained herein may be restricted by law in certain jurisdictions. Persons into whose possession any of the documents or other information contained herein come should inform themselves about and observe any such restrictions. Any failure to comply with any such restrictions may constitute a violation of the securities laws or regulations of such jurisdiction.

This website (and the information contained herein) does not contain or constitute an offer of securities FOR SALE, OR SOLICITATION OF AN OFFER TO PURCHASE SECURITIES IN THE UNITED STATES, THE REPUBLIC OF IRELAND, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR IN any other jurisdiction if to do so would constitute a violation of the relevant laws of, or require registration thereunder in, such jurisdiction. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), and may not be offered or sold in the United States unless the securities are registered under the Securities Act, EXCEPT PURSUANT TO an exemption from, OR IN A TRANSACTION NOT SUBJECT TO, the registration requirements of the Securities Act. There will be no PUBLIC offer of such securities in the United States. The information contained in the following pages is not INTENDED FOR DISTRIBUTION OR TRANSMISSION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR IN ANY OTHER JURISDICTION IF TO DO SO WOULD constitute a violation of the relevant laws of, or require registration thereunder in, such jurisdiction and by clicking on the acknowledgement button below you warrant and represent that you are not a resident of or located in, or a partnership or corporation organised or incorporated or registered in the United States, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA or in any other jurisdiction if to do so would constitute a violation of the relevant laws of, or require registration thereunder in, such jurisdiction and agree that you will not transfer any of the information contained on this website to any person in the United States, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA or in any other jurisdiction if to do so would constitute a violation of the relevant laws of, or require registration thereunder in, such jurisdiction.

Basis of access

Access to electronic versions of these materials is being made available on this website by in good faith and for information purposes only. Any person seeking access to website represents and warrants to Netscientific plc that they are doing so for information purposes only. Making press announcements and other documents available in electronic format does not constitute an offer to sell or the solicitation of an offer to buy securities in Netscientific plc. Further, it does not constitute a recommendation by Netscientific plc or any other party to sell or buy securities in Netscientific plc.

Confirmation of Understanding and Acceptance of Disclaimer

I ACKNOWLEDGE AND CONFIRM THAT I HAVE READ, UNDERSTOOD AND ACCEPT THE ABOVE TERMS AND CONDITIONS.

I HEREBY CERTIFY AND CONFIRM THAT I AM NOT A RESIDENT LOCATED, OR AN ENTITY FORMED, IN THE UNITED STATES, Australia, Canada, Japan or the Republic of South Africa OR IN ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF, OR REQUIRE REGISTRATION THEREUNDER IN, SUCH JURISDICTION.

I understand that it may affect my rights. I agree to be bound by its terms.
Disclaimer - Important - NetScientific